Canadian Multicenter Observational Study of Tysabri in Early Relapsing Remitting Multiple Sclerosis Participants (COSTAN)

This study has been terminated.
(Due to on-going enrollment challenges)
Sponsor:
Information provided by (Responsible Party):
Biogen
ClinicalTrials.gov Identifier:
NCT01706107
First received: October 11, 2012
Last updated: January 8, 2016
Last verified: December 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: January 2018
  Estimated Primary Completion Date: October 2017 (Final data collection date for primary outcome measure)